Camlin Fine Sciences has received an approval for raising funds upto Rs 250 crore by way of QIP/GDR/ADR/FCCB/other securities linked to equity / preference shares / any instrument or securities representing convertible securities. The board of directors at their meeting held on May 19, 2017 approved for the same.
Camlin Fine Chemicals is the world's second largest manufacturer and marketer of food grade antioxidants BHA (butylated hydroxyanisole) and TBHQ (Tertiary Butylhydroquinone).